Michael Rechtiene
Chief Executive Officer at Therakos, Inc.
Profile
Michael J.
Rechtiene is currently the Chief Executive Officer & Director at Therakos, Inc. and the President at Animas LLC.
Previously, he worked as a Principal at Johnson & Johnson, a Senior Advisor at PTV Sciences LP, and an Operating Advisor at Revival Healthcare Capital LLC.
He completed his undergraduate studies at San Diego State University and Villanova University in 1987.
He also holds an MBA from The Wharton School of the University of Pennsylvania, which he obtained in 1993.
Michael Rechtiene active positions
Companies | Position | Start |
---|---|---|
Therakos, Inc.
Therakos, Inc. Medical/Nursing ServicesHealth Services Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA. | Chief Executive Officer | 2013-01-01 |
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Animas LLC manufactures and distributes external insulin pumps for diabetes patients. The company was founded on November 5, 1996 and is headquartered in West Chester, PA. | President | - |
Former positions of Michael Rechtiene
Companies | Position | End |
---|---|---|
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018. The firm is headquartered in Austin, Texas. | Consultant / Advisor | 2023-05-31 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - |
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Private Equity Investor | - |
Training of Michael Rechtiene
San Diego State University | Undergraduate Degree |
Villanova University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Private companies | 4 |
---|---|
Therakos, Inc.
Therakos, Inc. Medical/Nursing ServicesHealth Services Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA. | Health Services |
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Finance |
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Animas LLC manufactures and distributes external insulin pumps for diabetes patients. The company was founded on November 5, 1996 and is headquartered in West Chester, PA. | Health Technology |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018. The firm is headquartered in Austin, Texas. | Finance |
- Stock Market
- Insiders
- Michael Rechtiene